Glycobiarsol
Names | |
---|---|
IUPAC name
Glycobiarsol | |
Systematic IUPAC name
Oxobismuthanyl hydrogen [4-(2-hydroxyacetamido)phenyl]arsonate | |
Other names
[4-[(2-Hydroxyacetyl)amino]phenyl]-oxobismuthanyl-oxyarsinic acid | |
Identifiers | |
116-49-4 | |
3D model (Jmol) | Interactive image |
ChemSpider | 10669861 |
ECHA InfoCard | 100.003.767 |
EC Number | 204-143-1 |
KEGG | D07358 |
PubChem | 16682839 |
UNII | E3U8347QWJ |
| |
| |
Properties | |
C8H9AsBiNO6 | |
Molar mass | 499.06 g·mol−1 |
Pharmacology | |
P01AR03 (WHO) QP51AD03 (WHO) | |
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa). | |
Infobox references | |
Glycobiarsol (trade name Milibis) is an antiprotozoal agent that has been used in humans[1] as well as in dogs.[2]
References
- ↑ Berberian, D. A. (1954). "The trichomonacidal activity of milibis (glycobiarsol)". New York state journal of medicine. 54 (22): 3102–3105. PMID 13214428.
- ↑ Kibble, R. M. (1969). "Glycobiarsol for the control of Trichuris vulpis infection in the dog". Australian Veterinary Journal. 45 (8): 387. doi:10.1111/j.1751-0813.1969.tb06633.x. PMID 5389346.
This article is issued from Wikipedia - version of the 8/3/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.